Interestingly, though regarded as biomarkers on mature lymphocytes [43], CD52 was found to be highly expressed by metastatic breast cancer cells and contributed to the interaction between breast cancer cells and T cells in lymph nodes by binding to SIGLEC10 [38]. The gene discussed is CD52; the disease is breast carcinoma.